nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—CHRNB4—Galantamine—Alzheimer's disease	0.423	0.501	CbGbCtD
Levomethadyl Acetate—CHRNA3—Galantamine—Alzheimer's disease	0.354	0.419	CbGbCtD
Levomethadyl Acetate—CYP3A4—Rivastigmine—Alzheimer's disease	0.0293	0.0347	CbGbCtD
Levomethadyl Acetate—CYP3A4—Donepezil—Alzheimer's disease	0.0234	0.0277	CbGbCtD
Levomethadyl Acetate—CYP3A4—Galantamine—Alzheimer's disease	0.0151	0.0179	CbGbCtD
Levomethadyl Acetate—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00467	0.206	CbGeAlD
Levomethadyl Acetate—Isoaminile—CA4—Alzheimer's disease	0.00286	0.571	CrCbGaD
Levomethadyl Acetate—CHRNA3—forebrain—Alzheimer's disease	0.002	0.0882	CbGeAlD
Levomethadyl Acetate—CHRNB4—nervous system—Alzheimer's disease	0.00177	0.078	CbGeAlD
Levomethadyl Acetate—CHRNB4—central nervous system—Alzheimer's disease	0.0017	0.0751	CbGeAlD
Levomethadyl Acetate—CHRNB4—brain—Alzheimer's disease	0.00135	0.0596	CbGeAlD
Levomethadyl Acetate—OPRM1—forebrain—Alzheimer's disease	0.00122	0.0537	CbGeAlD
Levomethadyl Acetate—OPRM1—telencephalon—Alzheimer's disease	0.00112	0.0494	CbGeAlD
Levomethadyl Acetate—CHRNA3—nervous system—Alzheimer's disease	0.00109	0.0479	CbGeAlD
Levomethadyl Acetate—CHRNA3—central nervous system—Alzheimer's disease	0.00105	0.0461	CbGeAlD
Levomethadyl Acetate—CYP19A1—forebrain—Alzheimer's disease	0.00102	0.0451	CbGeAlD
Levomethadyl Acetate—CHRNA3—cerebellum—Alzheimer's disease	0.00102	0.045	CbGeAlD
Levomethadyl Acetate—CHRNA3—brain—Alzheimer's disease	0.00083	0.0366	CbGeAlD
Levomethadyl Acetate—OPRM1—nervous system—Alzheimer's disease	0.000661	0.0292	CbGeAlD
Levomethadyl Acetate—OPRM1—central nervous system—Alzheimer's disease	0.000637	0.0281	CbGeAlD
Levomethadyl Acetate—CYP19A1—nervous system—Alzheimer's disease	0.000556	0.0245	CbGeAlD
Levomethadyl Acetate—CYP19A1—central nervous system—Alzheimer's disease	0.000535	0.0236	CbGeAlD
Levomethadyl Acetate—OPRM1—brain—Alzheimer's disease	0.000505	0.0223	CbGeAlD
Levomethadyl Acetate—Loperamide—CALM1—Alzheimer's disease	0.000448	0.0897	CrCbGaD
Levomethadyl Acetate—CYP19A1—brain—Alzheimer's disease	0.000425	0.0187	CbGeAlD
Levomethadyl Acetate—Phenoxybenzamine—CALM1—Alzheimer's disease	0.000394	0.0789	CrCbGaD
Levomethadyl Acetate—Promethazine—CALM1—Alzheimer's disease	0.000324	0.0649	CrCbGaD
Levomethadyl Acetate—CYP3A4—nervous system—Alzheimer's disease	0.000269	0.0119	CbGeAlD
Levomethadyl Acetate—CYP3A4—central nervous system—Alzheimer's disease	0.000259	0.0114	CbGeAlD
Levomethadyl Acetate—Tamoxifen—ESR1—Alzheimer's disease	0.000131	0.0263	CrCbGaD
Levomethadyl Acetate—Diphenhydramine—PTGS1—Alzheimer's disease	0.000118	0.0236	CrCbGaD
Levomethadyl Acetate—Dextropropoxyphene—CYP2D6—Alzheimer's disease	0.000114	0.0229	CrCbGaD
Levomethadyl Acetate—Loperamide—CYP2D6—Alzheimer's disease	0.000109	0.0218	CrCbGaD
Levomethadyl Acetate—Propiomazine—HTR2A—Alzheimer's disease	0.000102	0.0204	CrCbGaD
Levomethadyl Acetate—Promethazine—HTR2A—Alzheimer's disease	8.6e-05	0.0172	CrCbGaD
Levomethadyl Acetate—Diphenhydramine—CYP2D6—Alzheimer's disease	8.02e-05	0.0161	CrCbGaD
Levomethadyl Acetate—Promethazine—CYP2D6—Alzheimer's disease	7.87e-05	0.0157	CrCbGaD
Levomethadyl Acetate—Tamoxifen—CYP2D6—Alzheimer's disease	7.81e-05	0.0156	CrCbGaD
Levomethadyl Acetate—Methadone—CYP2D6—Alzheimer's disease	7.75e-05	0.0155	CrCbGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—AKT1—Alzheimer's disease	5.1e-05	0.000398	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	5.09e-05	0.000397	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	5.08e-05	0.000396	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ATP5A1—Alzheimer's disease	4.98e-05	0.000389	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CDK5—Alzheimer's disease	4.94e-05	0.000385	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CA4—Alzheimer's disease	4.85e-05	0.000379	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PLD3—Alzheimer's disease	4.75e-05	0.000371	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.75e-05	0.000371	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HTR6—Alzheimer's disease	4.75e-05	0.000371	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.7e-05	0.000366	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	4.58e-05	0.000357	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GAPDHS—Alzheimer's disease	4.56e-05	0.000356	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—HSD17B10—Alzheimer's disease	4.56e-05	0.000355	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	4.47e-05	0.000348	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	4.46e-05	0.000348	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.45e-05	0.000347	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP46A1—Alzheimer's disease	4.39e-05	0.000342	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	4.36e-05	0.00034	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—GAL—Alzheimer's disease	4.35e-05	0.000339	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ATP5A1—Alzheimer's disease	4.33e-05	0.000337	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ND1—Alzheimer's disease	4.24e-05	0.00033	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.14e-05	0.000323	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PLD3—Alzheimer's disease	4.13e-05	0.000322	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DHCR24—Alzheimer's disease	4.13e-05	0.000322	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—IL6—Alzheimer's disease	4.11e-05	0.00032	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—HSD17B10—Alzheimer's disease	3.96e-05	0.000309	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GAL—Alzheimer's disease	3.95e-05	0.000308	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	3.89e-05	0.000303	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TTR—Alzheimer's disease	3.85e-05	0.0003	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	3.83e-05	0.000298	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP46A1—Alzheimer's disease	3.81e-05	0.000297	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.79e-05	0.000295	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—AKT1—Alzheimer's disease	3.79e-05	0.000295	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ND1—Alzheimer's disease	3.68e-05	0.000287	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CA4—Alzheimer's disease	3.51e-05	0.000274	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—NPY—Alzheimer's disease	3.41e-05	0.000266	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	3.41e-05	0.000266	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCR5—Alzheimer's disease	3.4e-05	0.000265	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IAPP—Alzheimer's disease	3.39e-05	0.000265	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	3.39e-05	0.000264	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PYY—Alzheimer's disease	3.36e-05	0.000262	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—HTR2A—Alzheimer's disease	3.32e-05	0.000259	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	3.32e-05	0.000259	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	3.3e-05	0.000257	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CRH—Alzheimer's disease	3.29e-05	0.000257	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.27e-05	0.000255	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.26e-05	0.000255	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	3.13e-05	0.000244	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—NPS—Alzheimer's disease	3.12e-05	0.000243	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—NPY—Alzheimer's disease	3.1e-05	0.000242	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IAPP—Alzheimer's disease	3.08e-05	0.00024	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CRH—Alzheimer's disease	2.99e-05	0.000233	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PLD3—Alzheimer's disease	2.98e-05	0.000233	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—GAB2—Alzheimer's disease	2.98e-05	0.000232	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—SST—Alzheimer's disease	2.98e-05	0.000232	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.97e-05	0.000232	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	2.94e-05	0.000229	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CDK5—Alzheimer's disease	2.92e-05	0.000227	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—F2—Alzheimer's disease	2.91e-05	0.000227	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—APP—Alzheimer's disease	2.9e-05	0.000226	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	2.86e-05	0.000223	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—NPS—Alzheimer's disease	2.84e-05	0.000221	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.82e-05	0.00022	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR6—Alzheimer's disease	2.81e-05	0.000219	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	2.75e-05	0.000215	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.74e-05	0.000214	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TPI1—Alzheimer's disease	2.73e-05	0.000213	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CHAT—Alzheimer's disease	2.73e-05	0.000213	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GAB2—Alzheimer's disease	2.7e-05	0.000211	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—SST—Alzheimer's disease	2.7e-05	0.000211	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ND1—Alzheimer's disease	2.66e-05	0.000207	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—APP—Alzheimer's disease	2.64e-05	0.000206	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MAOB—Alzheimer's disease	2.62e-05	0.000204	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCL2—Alzheimer's disease	2.6e-05	0.000203	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PSENEN—Alzheimer's disease	2.55e-05	0.000199	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	2.52e-05	0.000196	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APH1A—Alzheimer's disease	2.51e-05	0.000196	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.49e-05	0.000194	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	2.49e-05	0.000194	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.48e-05	0.000193	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.47e-05	0.000192	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NCSTN—Alzheimer's disease	2.45e-05	0.000191	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—A2M—Alzheimer's disease	2.43e-05	0.00019	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LRP1—Alzheimer's disease	2.39e-05	0.000186	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TPI1—Alzheimer's disease	2.37e-05	0.000185	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CHAT—Alzheimer's disease	2.37e-05	0.000185	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GAL—Alzheimer's disease	2.33e-05	0.000182	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GFAP—Alzheimer's disease	2.33e-05	0.000182	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MAOB—Alzheimer's disease	2.27e-05	0.000177	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	2.19e-05	0.000171	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.17e-05	0.000169	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ACHE—Alzheimer's disease	2.12e-05	0.000165	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—A2M—Alzheimer's disease	2.11e-05	0.000165	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	2.09e-05	0.000163	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—A2M—Alzheimer's disease	2.05e-05	0.00016	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.03e-05	0.000158	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PSEN2—Alzheimer's disease	1.99e-05	0.000155	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	1.98e-05	0.000155	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ENO1—Alzheimer's disease	1.98e-05	0.000155	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	1.95e-05	0.000152	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.92e-05	0.00015	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.92e-05	0.00015	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.88e-05	0.000146	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—BCHE—Alzheimer's disease	1.84e-05	0.000144	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.84e-05	0.000143	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ACHE—Alzheimer's disease	1.84e-05	0.000143	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	1.83e-05	0.000143	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	1.82e-05	0.000142	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	1.82e-05	0.000142	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	1.77e-05	0.000138	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	1.74e-05	0.000136	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	1.74e-05	0.000136	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ENO1—Alzheimer's disease	1.72e-05	0.000134	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	1.72e-05	0.000134	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TPI1—Alzheimer's disease	1.71e-05	0.000134	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CHAT—Alzheimer's disease	1.71e-05	0.000134	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.71e-05	0.000133	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.71e-05	0.000133	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	1.69e-05	0.000132	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	1.69e-05	0.000132	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	1.67e-05	0.000131	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.67e-05	0.00013	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	1.65e-05	0.000128	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MAOB—Alzheimer's disease	1.64e-05	0.000128	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	1.64e-05	0.000128	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.63e-05	0.000127	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—BCHE—Alzheimer's disease	1.6e-05	0.000125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	1.6e-05	0.000125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SST—Alzheimer's disease	1.6e-05	0.000125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	1.6e-05	0.000125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	1.59e-05	0.000124	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	1.58e-05	0.000123	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	1.58e-05	0.000123	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APP—Alzheimer's disease	1.56e-05	0.000121	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.53e-05	0.00012	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—A2M—Alzheimer's disease	1.53e-05	0.000119	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	1.51e-05	0.000118	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	1.5e-05	0.000117	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	1.47e-05	0.000115	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	1.46e-05	0.000114	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.45e-05	0.000113	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	1.45e-05	0.000113	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	1.45e-05	0.000113	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.39e-05	0.000108	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	1.37e-05	0.000107	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	1.36e-05	0.000106	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	1.34e-05	0.000104	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	1.33e-05	0.000104	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.33e-05	0.000104	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ACHE—Alzheimer's disease	1.33e-05	0.000104	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—LPL—Alzheimer's disease	1.32e-05	0.000103	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	1.31e-05	0.000102	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.28e-05	9.98e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	1.27e-05	9.87e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	1.26e-05	9.84e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	1.26e-05	9.8e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ENO1—Alzheimer's disease	1.25e-05	9.71e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	1.25e-05	9.71e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.24e-05	9.64e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	1.22e-05	9.52e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	1.21e-05	9.4e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	1.19e-05	9.29e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	1.17e-05	9.09e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—BCHE—Alzheimer's disease	1.16e-05	9.03e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—LPL—Alzheimer's disease	1.15e-05	8.96e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	1.12e-05	8.71e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CALM1—Alzheimer's disease	1.11e-05	8.68e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—APOE—Alzheimer's disease	1.11e-05	8.65e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	1.11e-05	8.64e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CAV1—Alzheimer's disease	1.1e-05	8.57e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	1.09e-05	8.52e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	1.09e-05	8.47e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	1.06e-05	8.26e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	1.06e-05	8.25e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	1.03e-05	8.07e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	1.03e-05	8.03e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	1.01e-05	7.86e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CALM1—Alzheimer's disease	9.67e-06	7.54e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PPARG—Alzheimer's disease	9.66e-06	7.54e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—APOE—Alzheimer's disease	9.63e-06	7.51e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CAV1—Alzheimer's disease	9.55e-06	7.44e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—INS—Alzheimer's disease	9.48e-06	7.39e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	9.4e-06	7.33e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	9.37e-06	7.3e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	9.37e-06	7.3e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	9.28e-06	7.24e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	9.13e-06	7.12e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	9.08e-06	7.08e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	8.94e-06	6.97e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—F2—Alzheimer's disease	8.83e-06	6.89e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	8.64e-06	6.74e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PPARG—Alzheimer's disease	8.39e-06	6.54e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NOS3—Alzheimer's disease	8.31e-06	6.48e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—LPL—Alzheimer's disease	8.31e-06	6.48e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—INS—Alzheimer's disease	8.23e-06	6.42e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	8.11e-06	6.33e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	8.05e-06	6.27e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—INS—Alzheimer's disease	8e-06	6.24e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.97e-06	6.21e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.97e-06	6.21e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	7.87e-06	6.14e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	7.74e-06	6.04e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.64e-06	5.96e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	7.6e-06	5.93e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	7.48e-06	5.83e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7.35e-06	5.73e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NOS3—Alzheimer's disease	7.22e-06	5.63e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—A2M—Alzheimer's disease	7.1e-06	5.54e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	7.02e-06	5.47e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CALM1—Alzheimer's disease	6.99e-06	5.45e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—APOE—Alzheimer's disease	6.96e-06	5.43e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CAV1—Alzheimer's disease	6.9e-06	5.38e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	6.6e-06	5.15e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.18e-06	4.82e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.11e-06	4.76e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PPARG—Alzheimer's disease	6.07e-06	4.73e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	6.01e-06	4.69e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	5.96e-06	4.65e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—INS—Alzheimer's disease	5.95e-06	4.64e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	5.92e-06	4.62e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.79e-06	4.51e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.79e-06	4.51e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.68e-06	4.43e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	5.48e-06	4.27e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	5.46e-06	4.26e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.38e-06	4.2e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NOS3—Alzheimer's disease	5.22e-06	4.07e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.08e-06	3.96e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	5.06e-06	3.94e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.92e-06	3.84e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	4.77e-06	3.72e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	4.64e-06	3.62e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.24e-06	3.31e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.22e-06	3.29e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.86e-06	3.01e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—AKT1—Alzheimer's disease	3.82e-06	2.98e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	3.82e-06	2.98e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	3.5e-06	2.73e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.48e-06	2.71e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—AKT1—Alzheimer's disease	3.32e-06	2.59e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.25e-06	2.53e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.24e-06	2.52e-05	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	3.23e-06	2.52e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.21e-06	2.5e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.82e-06	2.2e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—INS—Alzheimer's disease	2.77e-06	2.16e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.43e-06	1.89e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—AKT1—Alzheimer's disease	2.4e-06	1.87e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.22e-06	1.73e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.11e-06	8.69e-06	CbGpPWpGaD
